Emma Catherine Fink MD

Hematologic Oncology

Fellow

450 Brookline Ave# SMITH353Boston, MA 02215
Phone+1 585-216-5801

Dr. Fink is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fink's full profile Already have an account?

Education & Training

Harvard Medical SchoolClass of 2020

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2020 - 2027
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

6 citations
Covariation MS uncovers a protein that controls cysteine catabolism.
Haopeng Xiao, Martha Ordonez, Emma C Fink, Taylor A Covington, Hilina B Woldemichael
Nature. 2025-11-01
41 citations
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells.
Rob S Sellar, Adam S Sperling, Mikołaj Słabicki, Jessica A Gasser, Marie E McConkey
The Journal of Clinical Investigation. 2022-08-15
322 citations
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Mikolaj Slabicki, Zuzanna Kozicka, Georg Petzold, Yen-Der Li, Manisha Manojkumar
Nature. 2020-06-03